Additional file 1 of CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals

Additional file 1: Supplementary figure 1. Baseline CSF tau368 concentrations. Supplementary figure 2. Correlation between CSF tau, cognition and tau PET with age. Supplementary figure 3. ROC curves for identifying Braak stages. Supplementary figure 4. Correlation between CSF tau biomarkers and hippocampal volume. Supplementary table 1. Correlation between CSF tau biomarkers and tau PET SUVr. Supplementary table 2. Correlations with tau PET imaging and cognition using ratios with p-tau in the group with symptomatic AD. Supplementary table 3. The relationship between CSF p-tau217 and PET imaging. Supplementary table 4. The relationship between CSF p-tau181 and PET imaging. Supplementary table 5. The relationship between CSF t-tau and PET imaging. Supplementary table 6. Correlation between global cognition and CSF biomarkers in the whole group.